Ocular insert housing steroid in two different therapeutic forms

Details Ocular insert housing steroid in two different therapeutic forms Ocular insert housing steroid in two different therapeutic forms

1980-10-14

1981-12-08

Rose, Shep K.

Drug, bio-affecting and body treating compositions

Identification or warning feature

Taste or smell or chemical irritation to the eye, nose, or...

424 19, 424 22, 424 28, 424239, 128260, A61K 922

Patent

active

043047653

ABSTRACT:
An ocular insert and an ocular composition are disclosed. The insert and the composition comprises a steroid in two different forms.

REFERENCES:
patent: 2932606 (1960-04-01), Shull et al.
patent: 2978379 (1961-04-01), Shell
patent: 3073743 (1963-01-01), Spero
patent: 3105795 (1963-10-01), Nobile
patent: 3134718 (1964-05-01), Nobile
patent: 3138527 (1964-06-01), Spero et al.
patent: 3197367 (1965-07-01), Panzarella
patent: 3743741 (1973-07-01), Laurent et al.
patent: 3780176 (1973-12-01), Young
patent: 3867519 (1975-02-01), Michaels
patent: 3923939 (1975-12-01), Baker et al.
patent: 3934013 (1976-01-01), Poulsen
patent: 3962414 (1976-06-01), Michaels
patent: 3968201 (1976-07-01), Ryde et al.
patent: 4001388 (1977-01-01), Shell
patent: 4052505 (1977-10-01), Higuchi et al.
patent: 4057619 (1977-11-01), Higuchi et al.
patent: 4115544 (1978-09-01), Shell
patent: 4164559 (1979-08-01), Miyata et al.
patent: 4177256 (1979-12-01), Michaels et al.
patent: 4179497 (1979-12-01), Cohen et al.
patent: 4186184 (1980-01-01), Zaffaroni
Haleblian et al., J. Pharm. Sci. 58(8):911-929, Aug. 1969, Pharmaceutical Applications of Polymorphism.
Haleblian et al., J. Pharm. Sci., 60(10):1485-1491, Oct. 1971, Isolation and Characterization of Some Solid Phases of Fluprednisolone-Comparison of Dissolusion Rates of Different Crystalline Phases of Fluprednisolone by in Vitro and in Vivo Methods.
Haleblian et al., J. Pharm. Sci., 64(8):1269-1288, Aug. 1975, Characterization of Habits and Crystalline Modifications of Solids and Their Pharmaceutical Applications.
Higuchi et al., J. Pharm. Sci., 52(2):150-159, Feb. 1963, Polymorphism and Drug Availability Solubility Relationships in the Methyl Prednisolone System.
Higuchi et al., J. Pharm. Sci., 52(1):67-71, Jan. 1963, Dissolution Rates of Finely Divided Drug Powders I. Effect of a Distribution of Particle Sizes in a Diffusion Controlled Process.
Higuchi et al., J. Pharm. Sci., 52(2):162-164, Feb. 1963, Dissolution Rates of Finely Divided Drug Powders II. Micronized Methyl Prednisolone.

Affiliated with

Also associated with

Rating

Ocular insert housing steroid in two different therapeutic forms does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ocular insert housing steroid in two different therapeutic forms, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ocular insert housing steroid in two different therapeutic forms will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-567713